Literature DB >> 15522260

Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor.

Patricia E Ganey1, James P Luyendyk, Jane F Maddox, Robert A Roth.   

Abstract

Susceptibility to drug toxicity is influenced by a variety of factors, both genetic and environmental. The focus of this article is the evidence addressing the hypothesis that inflammation is both a result of and a susceptibility factor for drug toxicity, with an emphasis on liver as a target organ. Results of studies suggesting a role for inflammatory mediators in the hepatotoxicity caused by acetaminophen or ethanol are discussed. For several drugs, the evidence from animal models that concurrent inflammation increases injury is presented. In addition, the occurrence of adverse drug reactions in people with preexisting inflammatory diseases is considered. The special case of idiosyncratic drug reactions is discussed and the potential raised for development of animal models for this type of drug toxicity. The conclusion is that inflammatory factors should be considered as determinants of sensitivity to adverse drug reactions.

Entities:  

Mesh:

Year:  2004        PMID: 15522260     DOI: 10.1016/j.cbi.2004.09.002

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  45 in total

Review 1.  Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2010-06-10       Impact factor: 4.849

Review 2.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 3.  Mechanisms of drug toxicity and relevance to pharmaceutical development.

Authors:  F Peter Guengerich
Journal:  Drug Metab Pharmacokinet       Date:  2010-10-22       Impact factor: 3.614

4.  Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system.

Authors:  Wei Zou; Sachin S Devi; Erica Sparkenbaugh; Husam S Younis; Robert A Roth; Patricia E Ganey
Journal:  Toxicol Sci       Date:  2008-12-12       Impact factor: 4.849

5.  Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction.

Authors:  Kevin M Beggs; Aaron M Fullerton; Kazuhisa Miyakawa; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2013-10-04       Impact factor: 4.849

6.  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Authors:  Naga Chalasani; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Timothy Davern; Jose Serrano; Hongqiu Yang; James Rochon
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

7.  Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice.

Authors:  Juliane I Beier; James P Luyendyk; Luping Guo; Claudia von Montfort; Donald E Staunton; Gavin E Arteel
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

8.  Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one?

Authors:  Robert A Roth; Patricia E Ganey
Journal:  J Pharmacol Exp Ther       Date:  2009-12-17       Impact factor: 4.030

9.  A multipathway phosphoproteomic signaling network model of idiosyncratic drug- and inflammatory cytokine-induced toxicity in human hepatocytes.

Authors:  Benjamin D Cosgrove; Leonidas G Alexopoulos; Julio Saez-Rodriguez; Linda G Griffith; Douglas A Lauffenburger
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

10.  Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2008-09-26       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.